This compound is a nucleobase-containing molecular entity. It is structurally characterized as a sulfur-linked conjugate of an amino acid and a purine nucleoside.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Kanamycin A
pharmaceutical raw material
Methotrexate
pharmaceutical raw material
Ethopabate
pharmaceutical raw material
Nikethamide
pharmaceutical raw material
S-adenosyl-L-homocysteine zwitterion
research compound
(2R)-2-Amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid (non-preferred name)
pharmaceutical intermediate
Potassium [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate
research compound
2-Chloroadenosine hemidydrate
research compound
2-amino-4-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]butanoic acid
ZJUKTBDSGOFHSH-UHFFFAOYSA-N
C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CSCCC(C(=O)O)N)O)O)N
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.